Sources

13 Total Sources

FDA Orders Vision-Loss Warning on GLP-1 Drugs After 16,000-Patient Study

The Washington Post2h ago

FDA Mandates Vision Loss Warning for GLP-1 Medications

Anadolu Agency | English21m ago

US orders new warnings for GLP-1 drugs over potential rare vision loss risk

demokratis.co.id2h ago

FDA Adds Eye Risk Warning to GLP-1 Drug Labels

ABC10.com KXTV2h ago

GLP-1 drugs to include new warning about rare eye condition causing sudden blindness, FDA says | abc10.com

Medpage Today2h ago

FDA Slaps New Safety Warning on GLP-1 Drugs | MedPage Today

富途牛牛2h ago

FDA Requires Addition of Rare Eye Disease Warning for GLP-1 Drugs; Eli Lilly and Co and Novo-Nordisk A/S Respond

Journal Record23h ago

FDA adds eye condition warning to popular GLP-1 drugs

IndexBox, Inc.4h ago

FDA Adds Vision-Loss Warnings to GLP-1 Weight-Loss Drugs - News and Statistics - IndexBox

The Wall Street Journal2h ago

U.S. Regulators Warn GLP-1 Drugs Carry Possible Rare Blindness Risk - WSJ

FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness

WNEP Scranton/Wilkes-Barre2h ago

GLP-1 drugs to include new warning about rare eye condition causing sudden blindness, FDA says | wnep.com

Ophthalmology Times4h ago

FDA requires NAION warning across the GLP-1 receptor agonist class | Eye Care Network - Ophthalmology Times

GLP-1 drugs carry potential risk of rare eye condition NAION: FDA | STAT